During the past decade, Bay Heart Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bay Heart Group" #1 collaborator was "Medtronic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Bay Heart Group" are "Atrial Fibrillation" (4 trials), "Arrhythmias, Cardiac" (1 trials), "Atrial Fibrillation New Onset" (1 trials), "Atrial Flutter" (1 trials) and "Paroxysmal Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Bay Heart Group" in a lesser frequency.

Most popular intervention types in "Bay Heart Group" are "Device" (6 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Anti-arrhythmic drugs" (1 trials), "Antiarrhythmic drug" (1 trials), "Arctic Front Cardiac Cryoablation System" (1 trials), "ArcticLine Cardiac Cryoablation Catheter" (1 trials) and "Cryoablation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bay Heart Group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Bay Heart Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bay Heart Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bay Heart Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".